Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Biomarkers of Innate and Adaptive Immune Activation Associated with Symptoms and Immune Responses After Administration of a Single Dose of a Quadrivalent Inactivated Split Virus Influenza Vaccine to Healthy Young Adults.

NCT03160118 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03160118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03160118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Biomarkers of Innate and Adaptive Immune Activation Associated with Symptoms and Immune Responses After Administration of a Single Dose of a Quadrivalent Inactivated Split Virus Influenza Vaccine to Healthy Young Adults.
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
March 27, 2017
Completion date
June 28, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of influenza